At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, Mississauga’s Vital Biosciences astounded global leaders in lab medicine with its VitalOne innovation.
The compact device, the size of a desktop computer, aims to revolutionize blood diagnostics by delivering over 50 lab-grade test results covering 95% of routine lab orders to primary care sites.
Doctors can now test, diagnose, and treat patients within a single visit, with results available in just 20 minutes. Although still in late-stage development, VitalOne has already impressed experts and secured $48 million in funding.
This disruptive technology seeks to make high-quality diagnostics universally accessible, transforming the $85 billion diagnostics industry.
Want to know more? Check out the source code on Businesswire.com.